BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 14524272)

  • 1. [Asthma with hypersensitivity to aspirin].
    Nizankowska-Mogilnicka E
    Pol Merkur Lekarski; 2003 Jun; 14(84):561-5. PubMed ID: 14524272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broken balance in aspirin hypersensitivity.
    Szczeklik A; Sanak M
    Eur J Pharmacol; 2006 Mar; 533(1-3):145-55. PubMed ID: 16457808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences].
    de Weck A; Sanz ML; Gamboa P
    Bull Acad Natl Med; 2005 Jun; 189(6):1201-18; discussion 1218-20. PubMed ID: 16433444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthma and aspirin].
    Schiappoli M; Gani F; Frati F; Marcucci F; Senna G
    Recenti Prog Med; 2003 Feb; 94(2):79-87. PubMed ID: 12908375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin-sensitive asthma.
    Morwood K; Gillis D; Smith W; Kette F
    Intern Med J; 2005 Apr; 35(4):240-6. PubMed ID: 15836503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
    Schapowal AG; Simon HU; Schmitz-Schumann M
    Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
    Kowalski ML; Borowiec M; Kurowski M; Pawliczak R
    Allergy; 2007 Jun; 62(6):628-34. PubMed ID: 17508966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
    Fuentes-Beltrán A; Montes-Vizuet R; Valencia-Maqueda E; Negrete-García MC; García-Cruz Mde L; Teran LM
    Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma.
    Higashi A; Kumlin M; Higashi N; Daham K; Gaber F; Lindeberg A; James A; Skedinger M; Delin I; Gyllfors P; Dahlén SE; Dahlén B
    Int Arch Allergy Immunol; 2012; 158(3):299-306. PubMed ID: 22398682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.
    Kupczyk M; Kurmanowska Z; Kupryś-Lipińska I; Bocheńska-Marciniak M; Kuna P
    Respir Med; 2010 Oct; 104(10):1404-9. PubMed ID: 20452758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin-induced asthma as an important type of bronchial asthma].
    Sakakibara H; Suetsugu S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():106-15. PubMed ID: 8752493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
    Pfaar O; Klimek L
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
    Sanak M; Kiełbasa B; Bochenek G; Szczeklik A
    Clin Exp Allergy; 2004 Dec; 34(12):1899-904. PubMed ID: 15663565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesics and asthma.
    Szczeklik A; Nizankowska E; Mastalerz L; Szabo Z
    Am J Ther; 2002; 9(3):233-43. PubMed ID: 11941383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspirin and other nonsteroidal anti-inflammatory drugs hypersensitivity--mechanisms, diagnostics and treatment].
    Kupczyk M; Kuna P
    Pneumonol Alergol Pol; 2008; 76(5):366-77. PubMed ID: 19003768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.
    Nizankowska-Mogilnicka E; Bochenek G; Mastalerz L; Swierczyńska M; Picado C; Scadding G; Kowalski ML; Setkowicz M; Ring J; Brockow K; Bachert C; Wöhrl S; Dahlén B; Szczeklik A
    Allergy; 2007 Oct; 62(10):1111-8. PubMed ID: 17521312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do we know about the genetics of aspirin intolerance?
    Palikhe NS; Kim SH; Park HS
    J Clin Pharm Ther; 2008 Oct; 33(5):465-72. PubMed ID: 18834360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma.
    Micheletto C; Tognella S; Guerriero M; Dal Negro R
    Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):10-4. PubMed ID: 16544582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
    Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
    Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.